Potent PROTACs Targeting EGFR Mutants in Drug Discovery
Author:
Affiliation:
1. Usona Institute, Fitchburg, Wisconsin 53711-5300, United States
Publisher
American Chemical Society (ACS)
Subject
Organic Chemistry,Drug Discovery,Biochemistry
Link
https://pubs.acs.org/doi/pdf/10.1021/acsmedchemlett.2c00459
Reference6 articles.
1. A Review on Fused Pyrimidine Systems as EGFR Inhibitors and Their Structure–Activity Relationship
2. Advances in targeted therapy in non‐small cell lung cancer with actionable mutations and leptomeningeal metastasis
3. Development of Dual Inhibitors Targeting Epidermal Growth Factor Receptor in Cancer Therapy
4. Epidermal growth factor receptor-targeted therapy for the treatment of non-small cell lung cancer: a review of phase II and III trials
5. Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The role of protein post-translational modifications in prostate cancer;PeerJ;2024-08-12
2. EGFR degraders in non‐small‐cell lung cancer: Breakthrough and unresolved issue;Chemical Biology & Drug Design;2024-04
3. Characteristic roadmap of linker governs the rational design of PROTACs;Acta Pharmaceutica Sinica B;2024-04
4. Epidermal growth factor receptor PROTACs as an effective strategy for cancer therapy: A review;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2023-07
5. PROTACs: A novel strategy for cancer drug discovery and development;MedComm;2023-05-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3